We are live on ! Find out more
MNOV icon

MediciNova

30 hedge funds and large institutions have $7.4M invested in MediciNova in 2026 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.28% more ownership

Funds ownership: 10.7%10.98% (+0.28%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

4% less capital invested

Capital invested by funds: $7.7M → $7.4M (-$299K)

9% less funds holding

Funds holding: 3330 (-3)

11% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 9

29% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 7

Holders
30
Holders Change
-3
Holders Change %
-9.09%
% of All Funds
0.37%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
5
Increased
8
Reduced
9
Closed
7
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
HFS
26
Hantz Financial Services
Michigan
$6K -$103 -68 -2%
Morgan Stanley
27
Morgan Stanley
New York
$2.74K
BT
28
Banque Transatlantique
France
$2.62K +$2.8K +1,850 New
Northwestern Mutual Wealth Management
29
Northwestern Mutual Wealth Management
Wisconsin
$418
Osaic Holdings
30
Osaic Holdings
Arizona
$90
LWA
31
Lantern Wealth Advisors
New York
-$39.3K -30,000 Closed
Citadel Advisors
32
Citadel Advisors
Florida
-$37.6K -28,712 Closed
SG
33
StoneX Group
New York
-$25.2K -19,200 Closed
Two Sigma Advisers
34
Two Sigma Advisers
New York
-$17.7K -13,500 Closed
FPAS
35
Focus Partners Advisor Solutions
Missouri
-$13.1K -10,000 Closed
DS
36
DRW Securities
Illinois
-$821K -3,800 Closed
TRCT
37
Tower Research Capital (TRC)
New York
-$2.42K -1,846 Closed

MNOV Hedge Fund Activity: Q1 2026 in Review

30 of the 8,128 institutional investors tracked by Wall St. Rank reported a position in MediciNova (MNOV) for Q1 2026, worth a combined $7.4M — down 3.9% from $7.7M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of MNOV and 5 opened new positions — a net loss of 2 holders — while 9 trimmed existing stakes and 8 added.

The largest buyer was Barclays, adding an estimated $187K. The largest seller was DRW Securities, exiting entirely with an estimated $821K sold.

  • 30 institutional investors held MediciNova (MNOV) as of Q1 2026, down from 33 in Q4 2025.
  • Funds reported $7.4M of MediciNova stock for Q1 2026, down 3.9% quarter-over-quarter.
  • 5 funds opened new MediciNova positions in Q1 2026 and 7 closed out, a net change of -2 holders.
  • The largest MediciNova buyer in Q1 2026 was Barclays, an estimated $187K added.
  • The largest MediciNova seller in Q1 2026 was DRW Securities, an estimated $821K sold.

Based on aggregated 13F filings for Q1 2026.